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Abstract
Inthisstudy wewanted togaininsights into selectivitymechanisms between G-protein-coupled receptors (GPCR) and different
subtypes of G-proteins. The thyrotropin receptor (TSHR) binds G-proteins promiscuously and activates both Gs (cAMP) and Gq
(IP). Our goal was to dissect selectivity patterns for both pathways in the intracellular region of this receptor. We were
particularly interested in the participation of poorly investigated receptor parts. We systematically investigated the amino acids
of intracellularloop (ICL) 1 and helix 8 using site-directed mutagenesis alongside characterization of cAMP and IP accumulation.
Thisapproachwas guided byahomology model of activated TSHR incomplex withheterotrimeric Gq, usingthe X-ray structure
of opsin with a bound G-protein peptide as a structural template. We provide evidence that ICL1 is significantly involved in G-
protein activation and our model suggests potential interactions with subunits Ga as well as Gbc. Several amino acid
substitutions impaired both IP and cAMP accumulation. Moreover, we found a few residues in ICL1 (L440, T441, H443) and helix
8 (R687) that are sensitive for Gq but not for Gs activation. Conversely, not even one residue was found that selectively affects
cAMP accumulation only. Together with our previous mutagenesis data on ICL2 and ICL3 we provide here the first
systematically completed map of potential interfaces between TSHR and heterotrimeric G-protein. The TSHR/Gq-heterotrimer
complex is characterized by more selective interactions than the TSHR/Gs complex. In fact the receptor interface for binding Gs
is a subset of that for Gq and we postulate that this may be true for other GPCRs coupling these G-proteins. Our findings
support that G-protein coupling and preference is dominated by specific structural features at the intracellular region of the
activated GPCR but is completed byadditional complementary recognitionpatterns between receptor and G-proteinsubtypes.
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Introduction
G-protein coupled receptors (GPCRs) constitute the largest
group of transmembrane-spanning receptors, conveying the
extracellular signal into the intracellular region. They can be
activated by a wide variety of endogenous stimuli such as amino
acids, light photons, peptides, ions and (pher-)hormones (reviewed
in [1–4]). In humans around 850 GPCRs are known [5,6]. The
signaling process of these receptors is of high physiological
importance and several diseases are caused by GPCR malfunction
(reviewed in [4,7–10]). The relevance of the GPCRs is due to their
role as signal transducers and regulators. Several crystal structures
of family A GPCRs are available (reviewed in [11–13]).
At their intracellular region GPCRs bind to heterotrimeric
guanine nucleotide-binding proteins (G-proteins), which play a
crucial role in signal transduction towards second messenger
cascades. G-proteins can be found in plants, fungi, bacteria, animals
andprotozoa(reviewedin[14–16]).Thesubunitsarecalledalpha(a),
beta (b) and gamma (c) and several subspecies of each subunit are
known. G-protein activation induced by the receptor includes
structural shifts, an exchange of GDP for GTP in the a-subunit,
followed by separation of the Ga from the Gbc-subunits. Confor-
mational changes in the G-protein are thought to be sequential,
wherebyreceptorcontactsinduceadefinedshiftofG-proteinregions
relative to one another, mainly between the C-terminal a5 helix
(movement and rotation), the a2/3 region and the a4/b6 loops.
Since the opposite ends of a5, the b-strands and loops participate in
forming the binding pocket for GDP, these conformational changes
subsequently initiate specific structural modifications in the GDP
binding pocket (reviewed in [16]). Furthermore the subunits Ga/
Gbc separate from each other, which opens interfaces to other
contact partners like phospho-diesterase [17]. The complexed Gbc-
subunits are required to stabilize the receptor-Ga interface.
Formerly the ‘‘collision coupling’’ theory was proposed for the
receptor/G-protein interaction, however more recently an alter-
native pre-coupled scenario has been suggested based on FRET
results for particular receptors (reviewed in [16]). Knowledge
concerning the mechanism and regulation of receptor/G-protein
interaction is growing including processes like receptor/G-protein
coupling [18,19], (selective) interaction patterns [20,21], structural
movement(s) of receptor and G-protein relative to one another
[19,22,23] and kinetics of interaction [1,16,19].
In this study we wanted to gain insights into activation and
selectivity mechanisms between GPCR and different subtypes of
G-proteins. The thyrotropin receptor (TSHR) binds G-proteins in
a promiscuous manner and activates both Gs and Gq [24–26]. We
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patterns at the intracellular receptor regions, with focus on
intracellular loop (ICL) 1, that was, to our knowledge, had hardly
been investigated or reported to be involved in the regulation of G-
protein activation of GPCRs (reviewed in [27]). Together with the
luteinizing hormone/chorionic gonadotropin receptor (LHCGR)
and the follicle-stimulating hormone receptor (FSHR), the TSHR
belongs to the glycoprotein-hormone receptor (GPHR) subfamily
of family A G-protein-coupled receptors. The TSHR is an
important key-player in endocrine signaling cascades and was
recently demonstrated to be of high physiological importance for
thyroid function by causing stimulation of phospholipase C via
Gq/11-activation through a secondary pathway [28,29]. There is
also evidence of a secondary pathway of phospholipase C
activation for the homologous LHCGR [30] and FSHR [31,32].
Interestingly, it was shown that the LHCGR couples to both Gs
and Gi, with bc-subunits released from either G-protein
contributing to the stimulation of phospholipase C-beta isoforms
[33,34].
Utilizing the active opsin structure in complex with a transducin
peptide [35,36] and the consequential orientation between
receptor and G-protein, we initially built a model of activated
TSHR that is bound with heterotrimeric Gq. Several new amino
acid contacts between the TSHR and G-protein are suggested by
this model, especially at ICL1 and helix 8. We performed model-
driven site-directed mutagenesis of this loop and flanking
transitions (the parts of transmembrane helices (TMHs) that
extend outside of the membrane) to the TMH 1 and 2 and
characterized functional properties of the mutated receptors. In
light of the activated opsin structure bound with transducin,
integration of our ICL1 results with our previous data for ICL2
and ICL3 [37,38] has allowed us to provide and discuss for the
first time a completed map of potential intracellular interfaces
between TSHR and heterotrimeric G-protein. The map encom-
passes intermolecular recognition and mechanisms of selectivity
comprised by patterns of selective interactions and specific
structural properties.
Results
Molecular homology models of the active TSHR
conformation in complex with the Gq heterotrimer
The crystal structure of opsin in complex with the C-terminal
helical peptide of transducin (Figure 1A) was used as a structural
Figure 1. Opsin in complex with a transducin peptide. A) The crystal structure of Opsin (light blue) in complex with a synthetic peptide (green)
of the C-terminal region of transducin (G-protein) (PDB entry 3DQB) was used as a structural template to build B) a homology model of the active
TSHR conformation (without the N-terminal extracellular region) coupled with Gq heterotrimer (Gaqbc). The superimposition of the C-terminal
residues (green) of the Gaq-protein model with the helical fragment of transducin from the X-ray structure allows a reliable orientation of the
complex.
doi:10.1371/journal.pone.0009745.g001
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conformation (without N-terminal extracellular domains) coupled
to the Gq heterotrimer (Figure 1B). The structural template,
rhodopsin/opsin, couples to transducin and Gq as well [35,36,39].
Due to the fact that TSHR is also known to couple to Gq
[24,25,40] and as Gq shows higher sequence similarity to
transducin than to Gs, we restricted our modeling study to the
TSHR/Gq heterotrimer complex. In agreement with previous
models [41] the C-terminal tail of the a5-helix of Gaq points
directly into an intracellular cleft of the TSHR between helices 3,
5, 6 and 7, but for the first time the superimposition of the C-
terminal residues of Gaq-protein with the helical transducin
fragment can serve as a fixation point for orientation of the
receptor to the G-protein. This allows a reliable orientation of the
complex between TSHR and heterotrimeric Gq to be made
(Figure 1B). Subsequent predictions about selective interactions,
such as between helix 8 of TSHR and Gaq but not with Gas, were
experimentally confirmed. The model is also generally in
accordance with the recently suggested movement of an activating
switch at the rhodopsin/transducin interface regarding the R*-Gt-
GDP complex [19]. Furthermore our model is consistent with
GPCRs that have a large third intracellular loop like the dopamine
receptors, which allows spatial extension of ICL3 alongside the Ga
subunit without steric hindrance of G-protein coupling.
Functional characterization of mutations within the
intracellular regions of TSHR
Amino acids of intracellular loop 1 and the transitions between
this loop and transmembrane helix 1 and 2 were systematically
mutated to alanine (region I438-F451, Table 1). Amino acid
substitutions of H443 and R450 decreased the IP accumulation
and were suggested by the homology model to interact directly
with Gaq and Gb, respectively (Figure 2). Furthermore, at position
450 a naturally occurring loss-of-function mutation R450H has
been reported [42]. Therefore, we investigated biophysical
properties of H443 and R450 by additional side-chain substitu-
tions (Table 2). In addition, our molecular homology model of the
TSHR/Gq complex predicted the involvement of R687 in the
intermolecular interaction between helix 8 of the receptor and
amino acid D313 in the a4-b6 loop of Gaq. We constructed the
R687A mutation and tested it functionally.
Cell surface expression. FACS analyses revealed that the
mutations showed a cell surface expression in the range of 49 to
108% of wt TSHR (Table 1).
The expression rate of mutants L446A, N447A and F451A was
less than 60% of the wild type. Our molecular homology model
suggests conformational functions for these amino acids whereby
they form stabilizing intramolecular interactions. The side-chains
of L446 and N447 were involved in stabilizing the loop
conformation, while F451 is located on the junction between
ICL1 and TMH2 and interacts with two hydrophobic residues of
TMH4. We suggest that the observed decreased cAMP or IP
accumulation for these residues might be caused indirectly by a
structural misfold, which causes decreased receptor transport to
the cell-surface, rather than based on interruption of direct G-
protein contacts.
cAMP accumulation. Mutation L439A in TMH1 was
characterized by an increased basal Gas mediated cAMP
signaling compared to wt (Table 1). In contrast to this newly
identified constitutively activating mutation (CAM) the mutants
L440A, T441A, S442A, Y444A, V448A and R450A displayed
decreased basal cAMP accumulation. For most of the mutants
TSH-mediated cAMP accumulation was comparable to wild type
or slightly decreased (not under 50% compared to maximum of
Table 1. Alanine mutagenesis and functional characterization of amino acids in the ICL1 and transitions to the helices 1 and 2.
Construct Cell surface expression cAMP accumulation IP accumulation [IPs (%IP/IPs + PI)]
FACS % of wt TSHR basal 100 mU/ml TSH constitutive activity (slope) basal 100 mU/ml TSH
wt TSHR 100 1 16.660.8 1 3.060.3 25.161.0
pcDNA 361 0.260.1 0.360.1 – 3.760.4 3.760.4
I438A 10866 0.860.3 9.361.3
b – 2.560.9 4.161.1
c
L439A 9565 2.960.5
a 16.960.7 3.760.6
c 2.660.5 22.360.5
L440A 8365
b 0.660.1 15.661.3 – 2.860.7 14.160.9
c
T441A 8267
a 0.560.1 14.161.3 – 3.560.7 8.660.2
c
S442A 8964 0.560.1 10.261.2
b – 3.260.6 9.760.5
c
H443A 9465 0.760.1 13.561.4 – 3.060.8 11.760.3
c
Y444A 10467 0.660.1 16.161.6 – 2.960.6 17.560.7
c
K445A 9266 0.760.2 14.861.6 – 3.360.3 19.960.9
c
L446A 5263
a 0.560.1 15.161.2 – 2.960.5 12.361.2
c
N447A 5764
a 0.760.0 13.761.1 – 2.960.6 9.960.7
c
V448A 71610
b 0.660.1 14.960.8 –– 2.560.1 16.762.3
c
P449A 9267
a 0.960.1 18.661.8 – 3.360.3 26.863.1
R450A 8167
b 0.460.1 11.761.5
b – 3.460.4 4.160.5
c
F451A 4966
a 0.560.1 11.961.6
c – 3.160.3 10.860.9
c
COS-7 cells were transfected with wt TSHR or various mutant TSHRs. The vector pcDNA3.1(2) / hygromycin was used as a control. The TSHR is characterized by an
elevated cAMP level compared to the control vector alone [76]. Therefore, cAMP accumulation is expressed relative to wt TSHR basal level. TSH-mediated levels of cAMP
and IP accumulation were determined after treatment of cells with 100 mU/ml bTSH. Expression of wt and mutant TSHRs were quantified on a FACS flow cytometer.
Data are given as mean 6 standard deviation (SD) of at least three independent experiments (n=3), each carried out in duplicate. Constitutive activity by linear
regression analyses was determined for mutant L439A.
aP,0.001,
bP=0.001 to 0.01,
cP=0.01 to 0.05.
doi:10.1371/journal.pone.0009745.t001
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which have significantly impaired signaling activity.
Inositol phosphate (IP) accumulation. None of the
characterized mutations had an increased basal IP level. TSH-
stimulated IP production is markedly reduced by alanine
substitutions of I438, L440, T441, S442, H443 and R450
(Tables 1 and 2).
Side-chain variations of H443 and R450. The side-chain
variations of H443 (Table 2) showed that a glutamate at this
position leads to a decreased IP accumulation and that a
phenylalanine side-chain impaired Gq mediated signaling. In
contrast, an arginine mutation at position 443 showed signaling
activity similar to the wild type. Upon variation of R450, the
glutamate substitution impaired both signaling pathways, while
Figure 2. Homology model of the complex of TSHR/Gq with focus on the interface between ICL1 and Gq heterotrimer. The TSHR
model suggests that in ICL1 (red) and in the transitions with the adjacent transmembrane helices (pale pink) the signaling sensitive amino acids
(H443, R450) directly contact Gbc (blue) and Gaq (C-term a5-helix: green), respectively. Dashed lines represent potential H-bonds. Others may
indirectly affect Gq coupling (e.g. T441) via conformational changes of ICL1.
doi:10.1371/journal.pone.0009745.g002
Table 2. Side-chain variations and functional characterization of H443 and R450 in ICL1 and transition to helix 2 and R687 in helix
8.
Construct Cell surface expression cAMP accumulation IP accumulation [IPs (%IP/IPs + PI)]
FACS % of wt TSHR basal 100mU/ml TSH basal 100mU/ml TSH
wt TSHR 100 1 13.761.1 1.960.2 23.862.6
pcDNA 460 0.260.1 0.260.1 2.160.2 2.260.2
H443F 7764
b 0.560.1 10.561.1 1.960.3 3.160.3
c
H443E 9964 0.560.1 10.960.4 1.960.3 12.861.9
c
H443R 10362 0.960.1 14.360.8 2.060.2 22.962.5
R450Q 9261 0.460.1 9.161.2
c 2.460.1 8.360.6
c
R450E 8666 0.360.1 4.860.6
c 2.460.2 2.560.2
b
R450K 8065 0.560.1 12.560.3 2.260.2 7.361.1
c
R450M 6165
c 0.560.2 11.760.5 2.060.3 3.160.5
b
R687A 6965
c 1.060.2 10.960.8 2.361.0 7.860.6
b
COS-7 cells were transfected with wt TSHR or various mutant TSHRs. The vector pcDNA3.1(2) /hygromycin was used as a control. The TSHR is characterized by an
elevated cAMP level compared to the control vector alone [76]. Therefore, cAMP accumulation is expressed relative to wt TSHR basal level. TSH-mediated levels of cAMP
and IP accumulation were determined after treatment of cells with 100 mU/ml bTSH. Expression of wt and mutant TSHRs were quantified on a FACS flow cytometer.
Data are given as mean 6 standard deviation (SD) of at least three independent experiments (n=3), each carried out in duplicate.
aP,0.001,
bP=0.001 to 0.01,
cP=0.01
to 0.05.
doi:10.1371/journal.pone.0009745.t002
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signaling only. Interestingly, the R450M substitution showed
cAMP accumulation of around 80% of the wild type. Our model
predicted that R687 in helix 8 interacts with Gaq selectively.
Indeed mutation R687A decreased the IP accumulation
significantly to 25% of the wild type without affecting cAMP
signaling (Table 2).
Amino acids of the ICL1 and transition to TMH2
potentially interact with both Gaq and Gbc
The signaling-sensitive amino acids identified here are observed
in our homology models to interact either directly via H-bonds (for
example R450 with E349 of the C-terminal helix of Gaq and
H443 with Gbc) or (Figure 2) indirectly affect G-protein activation
via conformational changes within intracellular loop 1. Our new
results summarized together with our recently published data
[41,43] of intracellular key-players for G-protein coupling with the
TSHR (GPHR information resources: http://www.ssfa-gphr.de
[44] and http://gris.ulb.ac.be [45]), suggest a multiple contact
interface between the TSHR and the G-protein heterotrimer of
Gq (Figure 3, Table 3). All three ICLs of the TSHR contribute to
the G-protein coupling process. Amino acids of ICL1 and the
transitions between ICL1/TMH2, TMH3/ICL2 and ICL3/
TMH6 as well as helix 8 potentially interact with Gaq, while
the ICL1 also interacts with Gbc.
Discussion
Despite fast progress in the investigation of molecular
mechanisms concerning contacts between receptor and G-protein
[18,19,22] or mechanisms of G-protein activation, fundamental
questions regarding these processes are still open such as: How and
where the G-protein selectivity of GPCRs is determined? Several
hypotheses regarding this question are under discussion (reviewed
in [27,46]), two important of them are: 1) Different conformational
states of the receptor are responsible for selectivity for certain G-
protein subtypes, since extracellular mutations and different small
ligands can cause different G-protein-subtype preferences for one
receptor [10,27,46–48]. 2) Distinctive selective interaction patterns
in terms of particular intracellular residues exist, which are
responsible for G-protein subtype specific interactions [20,21].
A definitive answer in favour of one of the hypotheses cannot be
given yet, but a combination between both mechanisms may be
more probable. We were interested in the identification of
molecular determinants of as yet unknown contribution to
coupling and activation mechanism between TSHR and G-
proteins (Gs and Gq) to add new information to this field.
Distinct amino acid side-chains of the ICL1 and its spatial
conformation are important for (selective) G-protein
activation
We identified L439A in TMH1 as a new CAM with elevated
basal CAMP activation. Alanine mutations of I438 and S442 in
ICL1 and R450 at the junction with TMH2 decrease both cAMP
and IP-mediated cascades, while L440A, T441A and H443A in
ICL1 impair IP activation selectively. It is to mention that these
functional data are derived in COS-cells as an overexpression
system for the GPHRs. For the GPHRs [49] like for other GPCRs
it is known that different levels of expression can modify signaling
capabilities due to different properties of the systems [50].
However the general comparability between results determined
in different cell-type systems has been shown for the TSHR
recently [51]. Although the relevance of in vitro for in vivo situation
is still under discussion, two examples indicate their direct
Figure 3. Homology complex model of the TSHR/Gq heterotrimer with focus on the interface between helix 8 and the transition of
ICL3/transmembrane helix 6 with Gaq. Our new and recently published data of intracellular key-players for the TSHR and G-protein interaction
are summarized and mapped on to the 3D complex model. Several mutations in the intracellular region of the TSHR are known to prevent Gs and Gq
signaling simultaneously. All mutants show decreased cAMP production by TSH in conjunction with decreased activation of the IP pathway. The
following wild type amino acids should therefore be considered as commonly sensitive for regulation of the receptor/G-protein interplay: ICL1 - I438,
S442, R450; ICL2 - M527, R528, D530; ICL3/TMH6 - I622. Colour codes: purple - selectively impaired Gq activation by mutation; red - inactivating
mutants for Gs and Gq coupling and cyan - known constitutively activating mutants. Dashed lines indicate potential H-bonds.
doi:10.1371/journal.pone.0009745.g003
G-Protein Coupling of TSHR
PLoS ONE | www.plosone.org 5 March 2010 | Volume 5 | Issue 3 | e9745relationship for GPHRs. First, especially the in former times
questionable in vivo relevance of both cAMP and also IP signaling
pathways for the TSHR has now been clarified [28,29,40].
Second, overlap between in vitro and in vivo studies were recently
evidenced for signaling mechanisms at the LHCGR by a mouse-
model [52] which confirmed previous insights from in vitro studies
about the significance of GPHR trans- activation [53–55].
Therefore we conclude that our experimental data are most likely
relevant and that the investigated intracellular region is of
importance. Noticing the remarkable high conservation of some
amino acids and even of the conserved (short) length of ICL1
within GPCRs, our results about the G-protein sensitivity of ICL1
might also be important for other GPCRs.
One of our particular findings is that when mutated, R450,
which is in the transition between ICL1 and TMH2, affects cAMP
and IP accumulation (Table 1, 2). Our molecular homology model
suggests direct interactions of R450 to Gaq, particularly to E349 at
the C-terminus of the a5 helix (Figure 2, Table 3). Comparing the
amino acid sequence in the C-terminal region of Gaq and Gas
(Table 4) reveals that at the corresponding position of E349 in
Gaq, the hydrophilic amino acid glutamine is found in Gas. If the
interacting conformations of Gaq and Gas with TSHR were
identical then an interaction of R450 with the H-bond accepting
residue Q349 of Gas would be expected and indeed, the mutants
R450A,Q,E significantly change the biophysical properties and
impair both Gs and Gq subtype mediated signaling cascades.
However, since mutation R450M selectively impairs IP but not
cAMP accumulation (Table 2), we conclude that R450 of TSHR
does not interact with a hydrophilic residue such as Q349 in the C-
terminal region of Gas. Moreover, since the R450K mutant also
impairs IP (Gq) mediated signaling selectively, it is assumed that it
is not the positive charge but rather the full H-donator function
and/or size of the arginine in position 450 which is necessary for
establishing the Gaq specific interaction. Thus it follows that the
interacting conformation of Gas with the TSHR might be
different from that of Gaq.
Furthermore, histidine 443 is an important signaling sensitive
residue in ICL1, of which aromatic or hydrophobic amino acid
substitutions impair IP but not cAMP accumulation. In contrast,
H443 can be substituted by a positively charged arginine residue
without any effect, even a negatively charged glutamic acid shows
moderate (around 50%) influence compared to wild type function.
Altogether, we are able to dissect fairly precisely the potential
counterpart of side-chain H443 as being a hydrophilic and
uncharged residue at heterotrimeric Gq. Our new opsin-based
homology model of the TSHR/Gq complex (Figure 3) orientates
this particular part of ICL1 towards Gb. An asparagine (N313 in
Figure 2) located at the exterior of a ‘propeller-blade’ of the Gb-
subunit is therefore suggested as a potential interaction partner.
One has to take into account that by inducing a slight spatial tilt a
few conserved hydrophilic amino acids such as N313, N268 and
N293, which are found within a tight spatial neighbourhood in this
area of the propeller blades of Gb, are also potential interaction
partners of TSHR H443.
Determinants of the interfaces between the Thyrotropin
receptor and G-protein heterotrimer
In combination with known mutational data of the TSHR
(information resources of GPHR data: http://www.ssfa-gphr.de
[44] and http://gris.ulb.ac.be [45]) our new findings for the ICL1
and molecular model of the TSHR/heterotrimeric Gq complex
allow, for the first time, a systematically completed overview of
potential intermolecular contact interfaces at the ICLs (Figure 3).
It suggests that all three intracellular loops (and also helix 8) might
establish direct side-chain contacts with the a-subunit, but that
interaction between the ICL1 and the Gb-subunit also probably
exist in the coupled state (Table 3):
& the ICL3/TMH6 transition (TSHR) contacts the a4/b6 loop
(Gaq),
& ICL2 (TSHR) contacts the b2/3 loop (Gaq),
& components of the transitions ICL1/TMH2, TMH3/ICL2,
and ICL3/TMH6 of the receptor interact with the C-terminal
region of the a5 helix (Gaq),
& helix 8 (TSHR) provides charged interactions with the a4/b6
region (Gaq),
& interactions from the ICL1 to the Gb-subunit.
E/DRW motif (TMH3). Similar to observations in the
crystal structure of opsin the arginine of the DRY motif in
TMH3 (in the TSHR an ERW motif) forms an H-bond
interaction with the Gaq backbone at Y350 in the a5C -
Table 3. Potential direct intermolecular interaction partners
between TSHR and Gq.
G-protein TSHR
Localization G-
protein Gaq residue Localization
a5 E349 R450 ICL1/TMH2
a5 L343/L347 I523/F525 ICL2
b2-b3 S192 R528 ICL2
b2-b3 V193 L529 ICL2
aN R32 D530 ICL2
a4-b6 D315 K618/K621 ICL3/TMH6
a5 L347/V353 I622 TMH6
b2-b3 D313 R687 Helix 8
Gb
N313 H443 ICL1
The identification of potential interaction partners between TSHR and Gq was
carried out using the molecular homology model of the entire receptor/Gq
complex (Figure 3) in combination with functional data (GPHR information
resources: http://www.ssfa-gphr.de [44] and http://gris.ulb.ac.be [45]).
doi:10.1371/journal.pone.0009745.t003
Table 4. Comparison between Gaq, Gas, Gai and Gat.
GaqG asG aiG at
R32 A39 R32 R28
S192 K216 D193 D189
V193 V217 L194 L190
D313 D354 D315 D311
D315 R356 K317 K313
L343/L347 Q384/L388 I344/L348 I340/L344
E349 Q390 D350 D346
L347/V353 L388/L394 L348/F354 L344/F350
Corresponding residues of Gas, Gaia n dG at at positions where Gaqi s
suggested to interact with the TSHR in our homology model. These residues
were revealed by a sequence alignment of the alpha subunits.
doi:10.1371/journal.pone.0009745.t004
G-Protein Coupling of TSHR
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the GPCRs is well reported (reviewed in [56]).
ICL2. Furthermore, it was previously demonstrated by
mutagenesis studies that particular parts of ICL2 and ICL3
contribute to G-protein activation in the TSHR [41,43], as well as
in the homologous LHCGR [49,57–59] and the FSHR [60,61].
Within the ICL2 of the TSHR the residues M527, R528, D530
appeared to be critical for both Gs- and Gq-signaling mediated by
TSH, whereas alanine mutation of I523, F525 and L529 led to
selectively impaired Gq activation [43].
ICL3. Studies of ICL3 in TSHR comprised systematic
mutagenesis and the first model of the complex between TSHR
and Gq [41]. In this and in our new refined TSHR/Gq model the
middle region of ICL3 is not involved in direct G-protein
interaction. However, the junctions of TMH5/ICL3 and ICL3/
TMH6 of TSHR are known to be strongly involved in G-protein
activation. In detail, mutation K618A located in the transition
between ICL3 and TMH6 was reported to decrease Gq-mediated
IP only and not Gs-related cAMP accumulation [41]. Besides
being in very close proximity to the C-terminal region of a5 helix
(Gaq), we also suggest for K618 an ionic interaction with the
charged partner D315 in the a4/b6 loop of Gaq (Figure 3), which
is not present in Gas (R356, Table 4).
ICL1 and helix 8. Mutagenesis studies of ICL1 in TSHR
were performed in the early ’90s [37,38]. Through multiple
substitutions these studies have given the first hint that sensitivity
for G-protein activation, including Gq at the TSHR, can be found
in this loop. Here for the first time we systematically investigated
each amino acid in ICL1, including those in the flanking
peripheries of this loop, by alanine mutations and deciphered
their particular influence on intermolecular signal transduction
from the receptor to G-proteins. From this work we complete the
gaps in our knowledge about determinants that form the TSHR
interfaces for G-proteins. This includes the residues R450 and
H443 that probably interact with Gaq and Gbc, respectively (see
details above and Figure 2), but also the here suggested interaction
between helix 8 of the TSHR (R687) and a4/b6 loop (D313) of
Gaq (Figure 3).
Implications for selective G-protein activation by TSHR
There is a large body of functional data for TSHR mutants in
the intracellular loops that simultaneously affect both G-protein
subtypes Gs and Gq [41,43]. However, within the entire
intracellular portion several additional mutations have been
identified that selectively decrease IP-mediated secondary path-
ways only and not TSH-induced cAMP production. In contrast,
no single mutation that only affects cAMP (Gs) accumulation
induced by TSH has been yet observed in all three intracellular
loops of the receptor. What can be learnt from these findings? Our
results lead to the following conclusions:
& At first, the binding modes between TSHR and the
heterotrimeric G-protein subtypes Gs and Gq overlap partially
according to mutants affecting the pathways of both G-protein
subtypes.
& Secondly, regarding our identified selective IP mutants and the
absence of selective cAMP mutants, it needs more and specific
interaction points to achieve the full signaling activity in the
receptor/Gq- than in the receptor/Gs-heterotrimer complex.
The intracellular interface and the number of receptor contacts
for cAMP activation is almost a subset of that for IP activation.
This is probably due to a smaller number of interaction points
that are spatially accessible and sufficient for Gs.
& Third, Gq specific TSHR residues do not seem to interfere
with the interaction of TSHR with Gs. In other words, they are
not selective in terms of excluding or inhibiting other G-
protein subtypes. However, Gq specific residues are also
located in close spatial neighbourhood to, or even overlap with
Gs interacting residues (in proximity to C-terminal a5 helix).
This might be an indication for a likely, albeit small, but
different structural arrangement between complexes of
TSHR/Gs and TSHR/Gq to each other.
We therefore assume, in accordance with others [27,46,48], that
a specific preference of a GPCR for a particular G-protein subtype
is controlled by two major events: 1. particular structural features
of the activated receptor such as an accessible intracellular
conformation (e.g. an ‘‘open’’ or ‘‘widely open’’ surface) is
mandatory for subtype preference; 2. characteristic complemen-
tary biophysical/biochemical properties of particular interacting
residues (intermolecular interaction patterns between receptor and
G-protein) complete the G-protein subtype preference. These two
mechanisms act together, however, the particular conformation of
the intracellular region confers a specific recognition pattern.
There is experimental evidence that the intracellular confor-
mation is significant for binding distinct G-protein subtypes and
can comprise various locations distributed over the entire GPCR.
In the transmembrane region different types of agonists can trigger
diverse intracellular conformations, as shown for beta(2)-adrener-
gic receptor [62] as well as different signaling types [10]. In
contrast to the dual hormone related signal (Gs and Gq [30]), the
stimulation of the LHCGR by a small agonistic molecule only
induces activation of Gs [63]. For the TSHR it is reported that the
naturally occurring loss-of-function mutation, L653V [29], in
extracellular loop 3 leads to a selective impairment of IP but not of
cAMP accumulation after TSH treatment. Several mutations
identified by mutagenesis studies (L417V, TMH1 [64]; S562A,
ECL2 [64]; Y605A, TMH5 [41]; N658A, ECL3 [65]) of the
TSHR are characterized by the same functional finding. By
simultaneous combination of CAMs in the TSHR it was recently
shown that the transmembrane helices are characterized by
different preferences for cooperative amplification of Gs and Gq
mediated signaling pathways [66]. These examples indicate that
for full and multiple GPHR activation in terms of dual Gs and Gq
coupling, highly specific structural conformations of the intracel-
lular region must be induced by the entire receptor protein.
Subsequently, it is feasible that the structures of Gs and Gq adjust
slightly differently to the receptor conformation to allow in
each case optimal complementary intermolecular side-chain
interactions.
Moreover, we propose that as well as Ga the Gb subunit also
participates in this scenario. As a consequence of the particular
spatial orientation between receptor and heterotrimeric G-
protein derived from the opsin/transducin peptide structure, we
suggest that in the case of Gq interaction, parts of the TSH-
receptor’s ICL1 can also get in close proximity to the Gb subunit.
Thus due to our TSHR/Gq model, particular ICL1 residues with
selectively decreased IP accumulation upon mutation might
interact either directly with the Gb subunit or they are involved
with influencing the Gb subunit to support Gaq activation. The
activation mechanisms of nucleotide exchange at the Ga-subunit
are on the one hand initiated by specific TSHR/Ga interfaces
but on the other hand receptor/Gb contacts may have a
supporting role in a suitable TSHR/Ga interaction. This is in
line with reports where it is suggested that Gbc may help to
present Ga in the appropriate conformation to the receptor
(reviewed in [17]). However, it is known that the Gb-subunit itself
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our suggested intermolecular contacts of TSHR/Gb might be
necessary for separation of the Ga and Gbc subunits. Thereafter
Gb acts to directly regulate downstream signaling by inducing
second messengers like IP.
Taken together, GPCRs with promiscuous binding of G-
protein subtypes (like the TSHR) are promising targets for
investigating G-protein selectivity by studying determinants
responsible for differentiated G-protein activation. Utilizing
molecular models based on the crystal complex between
Opsin/Gt-peptide and functional data by site-directed mutagen-
esis, we identified intracellular interfaces between TSHR and
different G-proteins. We provide evidence that residues of ICL1
and adjacent transition to TMH2 are involved in Gq pre-
coupling and interact with Ga (C-terminal helix a5) and
potentially with Gbc as well. Apart from the identification of
residues that are commonly sensitive for Gs and Gq signaling, we
dissected new residues (in ICL1 and helix 8) that are selectively
involved in the regulation of IP (Gq) and not in the cAMP
pathway (Gs). In contrast, no single residue has yet been found in
the entire intracellular TSHR region that selectively affects
cAMP accumulation (Gs) only. Together with our previous data
on ICL2 and ICL3 we are able to provide a completed overview
of potential intermolecular contact interfaces between TSHR and
heterotrimeric G-protein. Based on this, we postulate that
binding modes and orientations between GPCR and Gs- and
Gq- heterotrimers partially overlap, however, in addition more
selective interactions are established in the receptor/Gq-hetero-
trimer complex compared to TSHR/Gs. Our findings support
that on the one hand G-protein preference is determined
specifically by structural features of the entire intracellular region
of the activated GPCR, but on the other hand is also completed
by complementary recognition patterns between receptor and G-
protein subtypes.
Materials and Methods
Structural Bioinformatics and Molecular Modeling
We used as a structural template the X-ray structure of opsin
(PDB code 3CAP [36]). Until recently, the available GPCR
structures for generation of homology models were b2-adrenergic
receptor (b2-AR), rhodopsin, and adenosine-receptor (reviewed in
[11,12,68,69]). These structures contain inverse agonists as
ligands, some of them are modified by silencing mutations or
proteins such as lysozyme are fused to keep the receptors in a more
rigid conformation [12,70].
In contrast, the structure of opsin lacks the inverse agonistic
ligand retinal, and represents structural features of an active
receptor conformation. Furthermore, in 2008 an opsin structure in
complex with a synthetic C-terminal transducin-peptide was
published (PDB code: 3DQB, [22]). This structure (Figure 1A)
was used to suggest a model of G-protein activation by rhodopsin,
including recognition, binding and activation of transducin [19].
Firstly, several TSHR-specific corrections were made in the
homology model of active TSHR based on opsin. In opsin
interactions of the side-chains of three consecutive threonines
(positions 2.59–2.61) with the helical backbone of the preceding
residues cause a structural bulge in TMH2. In the TSHR no
consecutive threonines exist in TMH2, which suggests the
presence of a regular a-helix. In TMH5, a minor change of
orientation (a twist of 10 to 15 degrees) of the N-terminal half of
the helix was generated due to the lack of a proline compared to
opsin/rhodopsin (position 5.50). Gaps of missing residues in the
loops of the template structure were closed by the ‘Loop Search’
tool implemented in Sybyl 8.1 (Tripos Inc., St. Louis, Missouri,
63144, USA).
The heterotrimeric Gq-protein model was generated using the
crystal structure of Gai (PDB entry 1GP2) as a template, which has
high sequence similarity to Gi. The very last C-terminal residues of
Gaq (343LQLNLKEYNAV), which are missing in the Gai
structure, were built using a nuclear magnetic resonance (NMR)
structure of an 11-residue C-terminal peptide (340IKENLK-
DCGLF) with mainly helical conformation (PDB entry 1AQG
[71]). The C-terminal helix a5o fG aq was extended by the latter
helical fragment. This conformation is also supported by the
helical conformation of the last 11 C-terminal residues of Gas
(384QRMHLRQYELL, PDB entry 1AZS).
The complex between Gq coupled to activated TSHR were
built by spatial superimposition of the C-terminal a-helix fragment
of Gaq with the corresponding synthetic a-helical C-terminal
peptide of transducin in the crystal structure. Side-chains and
loops of each homology model were subjected to conjugate
gradient minimization (until converging at a termination gradient
of 0.05 kcal/(mol*A ˚)) and molecular dynamics simulation (2ns) by
fixing the backbone of the transmembrane helices and beta-
strands. Finally the models were minimized without constraints.
All structure images were produced using PyMOL (DeLano WL,
version 0.99, San Carlos, CA, USA).
Site-directed Mutagenesis
TSHR mutants were constructed by PCR mutagenesis using the
human TSHR-pcDNA3.1(-)/hygro as a template as previously
described [72]. Mutated TSHR sequences were verified by
dideoxy sequencing with dRhodamine Terminator Cycle Se-
quencing chemistry (ABI Advanced Biotechnologies, Inc., Colum-
bia, MD).
Cell culture and transient expression of mutant TSHRs
COS-7 cells [73] were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FCS, 100 U/ml
penicillin and 100 mg/ml streptomycin (Gibco Life technologies,
Paisley, UK) at 37uC in a humidified 5% CO2 incubator. Cells
were transiently transfected using the GeneJammerH Transfection
Reagent (Stratagene, Amsterdam, NL). 12-well plates (16105
cells/well) were transfected with 1 mg DNA per well for
determination of cell surface expression and inositol phosphates.
24-well plates (0.5610
5 cells per well) with 500 ng DNA per well
were used for linear regression analysis and measuring of
intracellular cAMP accumulation.
FACS Analyses
The TSHR cell surface expression level was quantified on a
FACS flow cytometer. Transfected cells were detached from the
dishes with 1 mM EDTA and 1 mM EGTA in PBS and
transferred into Falcon 2054 tubes. Cells were washed once with
PBS and then incubated at 4uC for 1 h with a 1:400 dilution of a
mouse anti human TSHR antibody (2C11, 10 mg/l, Serotec Ltd.,
Oxford, UK) in the same buffer. Cells were washed twice and
incubated at 4uC for 1 h with a 1 :200 dilution of fluorescein-
conjugated F(ab’)2 rabbit anti mouse IgG (Serotec). Before FACS
analysis (FACscan Becton Dickinson and Co., Franklin Lakes, NJ,
USA) cells were washed twice and then fixed with 1%
paraformaldehyde. Receptor expression was determined by the
mean fluorescence intensity (MFI). The wt TSHR was set at 100%
and receptor expression of the mutants was calculated according
to this. The percentage of signal positive cells corresponds to
transfection efficiency, which was approximately 50–60% of viable
cells for each mutant.
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Forty eight hours after transfection, cells were incubated in the
absence or presence of 100 mU/ml bTSH (Sigma Chemical Co.)
in serum free medium supplemented with 1mM IBMX (Sigma) for
one hour. Reactions were terminated by aspiration of the medium.
The cells were washed once with ice-cold PBS and then lysed by
addition of 0.1 N HCl. Supernatants were collected and dried.
cAMP content of the cell extracts was determined using the cAMP
AlphaScreen
TM Assay (PerkinElmer
TM Life Sciences, Zaventem,
Belgium) according to the manufacturer’s instructions.
Linear regression analysis of constitutive activity as a
function of TSHR expression (slopes)
The constitutive activity is expressed as basal cAMP formation
as a function of receptor expression determined by FACS. COS-7
cells were transiently transfected in 24-well plates (0.5610
5 cells
per well) with increasing concentrations of wt or mutant TSHR
plasmid DNA (50; 100; 200; 300; 400 and 500 ng per well). The
total DNA amount was kept constant by cotransfection with empty
vector to the amount of the highest DNA concentration of 500 ng
per well. For determination of cell surface expression and basal
cAMP production see ‘‘FACS Analyses’’ and ‘‘cAMP Accumula-
tion Assay’’, respectively. Basal cAMP formation as a function of
receptor expression was analyzed according to Ballesteros et al
[74] using the linear regression module of GraphPad Prism 4 for
Windows.
Activation of Inositol Phosphate Formation
Transfected COS-7 cells were incubated with 2 mCi [myo-
3-
H]inositol (Amersham Biosciences, Braunschweig, Germany) for 6
h. Thereafter, cells were incubated with serum-free DMEM
containing 10 mM LiCl and 100 mU/ml TSH for the accumu-
lation of intracellular IPs. Evaluation of basal and TSH-induced
increases in intracellular IP levels was performed by anion
exchange chromatography as previously described [75]. IP-values
were expressed as the percentage of radioactivity incorporated
from [
3H] IP-1 to -3 over the sum of radioactivity incorporated in
IPs and phophatidylinositol.
Statistics
Statistical analysis was carried out using the Mann-Whitney
nonparametric t test using GraphPad Prism 4 for Windows (
ap-
value , 0.001 extremely significant;
bp-value 0.001 to 0.01 very
significant;
cp-value 0.01 to 0.05 significant; p-value . 0.05 not
significant).
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